Peter J. Worland
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Cancer-related Molecular Pathways, PI3K/AKT/mTOR signaling in cancer, Monoclonal and Polyclonal Antibodies Research, Prostate Cancer Treatment and Research
Most-Cited Works
- Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.(1996)
- → Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.(1996)500 cited
- → UCN-01: a Potent Abrogator of G2 Checkpoint Function in Cancer Cells With Disrupted p53(1996)447 cited
- The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.(1997)
- → Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275(1992)350 cited
- → Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275(1994)346 cited
- → Identification of a selenocysteyl-tRNASer in mammalian cells that recognizes the nonsense codon, UGA(1989)284 cited
- → Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy(1996)277 cited
- Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol.(1999)
- → Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells.(1991)229 cited